References
- Brown J. K., Malone M. H. Some U.S. Street Drug Identification Programs. J. Amer. Pharm. Assn. 1973; NS13: 670–676
- Gupta R. C., Lu I., Oei G. ‐L., Lundberg G. D. Determination of Phencyclidine (PCP) in Urine and Illicit Street Drug Samples. Clin. Toxicol. 1975; 8: 611–621
- Gupta R. C. Street Drug Identification Program, Report for July 1975. Clin. Toxicol. 1976; 9: 281–293
- Lundberg G. D., Gupta R. C., Montgomery S. H. Phencyclidine: Patterns Seen in Street Drug Analysis. Clin. Toxicol. 1976; 9: 503–511
- PharmChem Research Foundation. The Street Drug Analysis Results. Clin. Toxicol. 1979; 14: 619–630
- Ritzlin R. S., Gupta R. C., Lundberg G. D. Delta‐9‐tetrahydrocannibinol Levels in Street Samples of Marijuana and Hashish: Correlation to User Reactions. Clin. Toxicol. 1979; 15: 45–53
- Brown J. K., Malone M. H. Status of Drug Quality in the Street‐Drug Market‐An Update. Clin. Toxicol. 1976; 9: 145–168
- Morgan J. P., Kagan D. Street Amphetamine Quality and the Controlled Substances Act of 1970. J. Psychedel. Drugs 1978; 10: 303–317
- Desmond D. P., Maddux J. F., Trevino A. Street Heroin Potency and Deaths from Overdose in San Antonio. Am. J. Drug Alcohol Abuse 1978; 5: 39–49
- Lake C. R., Quirk R. S. CNS Stimulants and the Lookalike Drugs. Psychiatr. Clin. North Am. 1984; 7: 689–701
- Schweitzer V. G. Osteolytic Sinusitis and Pneumomediastinum: Deceptive Otolaryngologic Complications of Cocaine Abuse. Laryngoscope 1986; 9: 206–210
- McGee M. B. Caffeine Poisoning in a 19 Year Old Female. J. Forensic. Sci. 1980; 25: 29–32
- May D. C., Long T., Madden R., Hurst H. E., Jarboe C. H. Caffeine Toxicity Secondary to Street Drug Ingestion [letter]. Ann. Emerg. Med. 1981; 10: 549
- Bernstein E., Diskart B. M. Phenylpropanolamine: A Potentially Hazardous Drug. Ann. Emerg. Med. 1982; 11: 311–315
- Jackson C., Hart A., Robinson M. D. Fatal Intracranial Hemorrhage Associated with Phenylpropanolamine, Pentazocine, and Tripelennamine Overdose. J. Emerg. Med. 1985; 3: 127–132
- Morgan J. P. Phenylpropanolamine. A Critical Analysis of Reported Adverse Reactions and Over dosage. J. K. Burgess, Inc., Fort Lee, New York 1986
- Phenylpropanolamine: Risks, Benefits, and Controversies (Clinical Pharmacology & Therapeutics Ser.: Vol. 5), J. P. Morgan, D. V. Kagan. Praeger, New York 1985